Tyra Biosciences, Inc. (TYRA)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$28.65+15.25%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · TYRA
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|---|
| Operating Expenses & Income | |||||||
| R&D Expenses | 126.3 | 102.9 | 80.1 | 62.5 | 43.0 | 20.6 | 7.2 |
| Operating Income | (160.5) | (132.8) | (104.2) | (79.9) | (58.9) | (26.3) | (9.3) |
| Earnings from Continuing Operations | |||||||
| Other Non-Operating Income / Expenses | 11.9 | 12.8 | 17.7 | 10.8 | 3.6 | (0.0) | (0.0) |
| Income Tax Expense | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | |||||||
| Net Income | (148.6) | (119.9) | (86.5) | (69.1) | (55.3) | (26.3) | (9.3) |
| Per Share | |||||||
| Basic EPS | (2.25) | (2.01) | (1.51) | (1.62) | (1.32) | (1.91) | — |
| Diluted EPS | (2.25) | (2.01) | (1.51) | (1.62) | (1.32) | (1.91) | — |
| Basic Weighted Avg Shares | 66.0 | 59.6 | 57.2 | 42.7 | 41.9 | 13.8 | — |
| Diluted Weighted Avg Shares | 66.0 | 59.6 | 57.2 | 42.7 | 41.9 | 13.8 | — |
| Supplemental | |||||||
| EBITDA | — | (132.2) | (103.7) | (79.6) | (58.6) | (26.1) | (9.3) |
| EBIT | (160.5) | (132.8) | (104.2) | (79.9) | (58.9) | (26.3) | (9.3) |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.